Updated Librela Charts Through 2026 Q1
FDA/CVM released the 2026 Q1 public adverse-event JSON files on July 3, 2026. I reran the Librela chart analysis to include the newly available quarter.
These updated charts extend the public JSON analysis through 2026 Q1.
The original petition charts submitted to FDA cover 2023 Q2 through 2025 Q4 and remain available on the petition charts page. Click here to view the original charts
Click on the chart to view a larger version.
All Cases
Individual dogs with death/euthanasia outcomes, including both monotherapy and polytherapy, 2023 Q2–2026 Q1.
Monotherapy
Individual dogs with death/euthanasia outcomes where Librela was the only listed drug.
All Cases: Time to Onset
Reported time from Librela injection to onset in individual dogs with death/euthanasia outcomes
Monotherapy: Time to Onset
Reported time to onset in individual dogs where Librela was the only listed drug
